C12Y 101/01247
Codeinone reductase
Official title: Codeinone reductase (NADPH) (1.1.1.247)
C12Y101/01247 (Codeinone reductase) appears on 5 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 11
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 2 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 1 | 3 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Methods of producing epimerases and benzylisoquinoline alkaloids16 Dec 2025US 12,497,638 B2The Board of Trustees of the Leland Stanford Junior University
- Methods of producing epimerases and benzylisoquinoline alkaloids2 Jan 2024US 11,859,225 B2The Board of Trustees of the Leland Stanford Junior University
- Compositions and methods for making (R)-reticuline and precursors thereof28 Mar 2023US 11,613,770 B2Antheia, Inc.
- Compositions and methods for making alkaloid morphinans12 Mar 2019US 10,227,353 B2Epimeron Inc.
- Compositions and methods for making (R)-Reticuline and precursors thereof29 Jan 2019US 10,190,141 B2Epimeron Inc.
- Methods of Producing Epimerases and Benzylisoquinoline Alkaloids4 Jul 2024US 2024/0218408 A1The Board of Trustees of the Leland Stanford Junior University
- Modulation of hypoxia associated with stroke25 Jan 2024US 2024/0026399 A1Omniox.Inc.
- Compositions and methods for making (r)-reticuline and precursors thereof4 Jan 2024US 2024/0002894 A1Antheia, Inc.
- Modulation of hypoxia associated with stroke29 Apr 2021US 2021/0121521 A1Omniox.Inc.
- Modulation hypoxia associated with stroke3 Sep 2020US 2020/0276265 A1Omniox.Inc.
Most cited
By later US patents